EMD-25449
RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain
EMD-25449
Single-particle30.0 Å
Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 17/01/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain
Deposition Authors: Thomas PV , Smith C, Chen WH , Sankhala RS , Hajduczki A, Choe M , Martinez E , Chang W, Peterson CE , Karch C , Gohain N , Kannadka CB, de Val N , Joyce MG , Modjarrad K
Sample: RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain
Deposition Authors: Thomas PV , Smith C, Chen WH , Sankhala RS , Hajduczki A, Choe M , Martinez E , Chang W, Peterson CE , Karch C , Gohain N , Kannadka CB, de Val N , Joyce MG , Modjarrad K
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Joyce MG ,
Chen WH ,
Sankhala RS ,
Hajduczki A,
Thomas PV ,
Choe M ,
Chang W,
Peterson CE ,
Martinez E ,
Morrison EB,
Smith C,
Ahmed A,
Wieczorek L,
Anderson A,
Chen RE,
Case JB,
Li Y,
Oertel T,
Rosado L,
Ganesh A,
Whalen C,
Carmen JM,
Mendez-Rivera L,
Karch C ,
Gohain N ,
Villar Z,
McCurdy D,
Beck Z,
Kim J,
Shrivastava S,
Jobe O,
Dussupt V,
Molnar S,
Tran U,
Kannadka CB,
Zemil M,
Khanh H,
Wu W,
Cole MA,
Duso DK,
Kummer LW,
Lang TJ,
Muncil SE,
Currier JR,
Krebs SJ,
Polonis VR,
Rajan S,
McTamney PM,
Esser MT,
Reiley WW,
Rolland M,
de Val N ,
Diamond MS,
Gromowski GD,
Matyas GR,
Rao M,
Michael NL,
Modjarrad K
(2021) Cell Rep
(2021) Cell Rep